About this Journal Submit a Manuscript Table of Contents
Stroke Research and Treatment
Volume 2013 (2013), Article ID 510481, 7 pages
http://dx.doi.org/10.1155/2013/510481
Review Article

Advances in the Critical Care Management of Ischemic Stroke

Department of Neurology, University of California-San Francisco, San Francisco General Hospital, 1001 Potrero Avenue, San Francisco, CA 94110, USA

Received 25 March 2013; Accepted 7 May 2013

Academic Editor: Majaz Moonis

Copyright © 2013 Vineeta Singh and Nancy J. Edwards. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. R. Zazulia, “Critical care management of acute ischemic stroke,” Continuum Lifelong Learning in Neurology, vol. 15, no. 3, pp. 68–82, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. M. N. Diringer and D. F. Edwards, “Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage,” Critical Care Medicine, vol. 29, no. 3, pp. 635–640, 2001. View at Scopus
  3. E. M. Bershad, E. S. Feen, O. H. Hernandez, M. F. K. Suri, and J. I. Suarez, “Impact of a specialized neurointensive care team on outcomes of critically ill acute ischemic stroke patients,” Neurocritical Care, vol. 9, no. 3, pp. 287–292, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. P. Broderick, Y. Y. Palesch, A. M. Demchuk, et al., “Endovascular therapy after intravenous t-PA versus t-PA alone for stroke,” The New England Journal of Medicine, vol. 368, no. 10, pp. 893–903, 2013. View at Publisher · View at Google Scholar
  5. A. Ciccone, L. Valvassori, M. Nichelatti, et al., “Endovascular treatment for acute ischemic stroke,” The New England Journal of Medicine, vol. 368, no. 10, pp. 904–913, 2013. View at Publisher · View at Google Scholar
  6. G. W. Albers, V. E. Bates, W. M. Clark, R. Bell, P. Verro, and S. A. Hamilton, “Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study,” Journal of the American Medical Association, vol. 283, no. 9, pp. 1145–1150, 2000. View at Scopus
  7. M. D. Hill and A. M. Buchan, “Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study,” CMAJ, vol. 172, no. 10, pp. 1307–1312, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. K. R. Lees, E. Bluhmki, R. von Kummer et al., “Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials,” The Lancet, vol. 375, no. 9727, pp. 1695–1703, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. E. C. Jauch, J. L. Saver, H. P. Adams, et al., “Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association,” Stroke, vol. 44, pp. 870–947, 2013. View at Publisher · View at Google Scholar
  10. J. Broderick, S. Connolly, E. Feldmann et al., “Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group,” Stroke, vol. 38, no. 6, pp. 2001–2023, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. M. D. Hill, T. Lye, H. Moss et al., “Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke,” Neurology, vol. 60, no. 9, pp. 1525–1527, 2003. View at Scopus
  12. C. M. Shaw, E. C. Alvord Jr., and R. G. Berry, “Swelling of the brain following ischemic infarction with arterial occlusion,” Archives of Neurology, vol. 1, pp. 161–177, 1959. View at Scopus
  13. W. Hacke, S. Schwab, M. Horn, M. Spranger, M. de Georgia, and R. von Kummer, “‘Malignant’ middle cerebral artery territory infarction: clinical course and prognostic signs,” Archives of Neurology, vol. 53, no. 4, pp. 309–315, 1996. View at Scopus
  14. E. F. M. Wijdicks and M. N. Diringer, “Middle cerebral artery territory infarction and early brain swelling: progression and effect of age on outcome,” Mayo Clinic Proceedings, vol. 73, no. 9, pp. 829–836, 1998. View at Scopus
  15. S. E. Kasner, A. M. Demchuk, J. Berrouschot et al., “Predictors of fatal brain edema in massive hemispheric ischemic stroke,” Stroke, vol. 32, no. 9, pp. 2117–2123, 2001. View at Scopus
  16. K. Vahedi, J. Hofmeijer, E. Juettler et al., “Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials,” Lancet Neurology, vol. 6, no. 3, pp. 215–222, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. H. B. Huttner and S. Schwab, “Malignant middle cerebral artery infarction: clinical characteristics, treatment strategies, and future perspectives,” The Lancet Neurology, vol. 8, no. 10, pp. 949–958, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Schwarz, S. Schwab, M. Bertram, A. Aschoff, and W. Hacke, “Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke,” Stroke, vol. 29, no. 8, pp. 1550–1555, 1998. View at Scopus
  19. H. Kamel, B. B. Navi, K. Nakagawa, J. C. Hemphill, and N. U. Ko, “Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials,” Critical Care Medicine, vol. 39, no. 3, pp. 554–559, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. J. M. Simard, M. Chen, K. V. Tarasov et al., “Newly expressed SUR1-regulated NCCa-ATP channel mediates cerebral edema after ischemic stroke,” Nature Medicine, vol. 12, no. 4, pp. 433–440, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. J. M. Simard, N. Tsymbalyuk, O. Tsymbalyuk, S. Ivanova, V. Yurovsky, and V. Gerzanich, “Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke,” Stroke, vol. 41, no. 3, pp. 531–537, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. J. M. Simard, S. K. Woo, G. T. Schwartzbauer, and V. Gerzanich, “Sulfonylurea receptor 1 in central nervous system injury: a focused review,” Journal of Cerebral Blood Flow & Metabolism, vol. 32, no. 9, pp. 1699–1717, 2012. View at Publisher · View at Google Scholar
  23. J. Leonardi-Bee, P. M. W. Bath, S. J. Phillips, and P. A. G. Sandercock, “Blood pressure and clinical outcomes in the international stroke trial,” Stroke, vol. 33, no. 5, pp. 1315–1320, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. E. C. Sandset, P. M. W. Bath, G. Boysen et al., “The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial,” The Lancet, vol. 377, no. 9767, pp. 741–750, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Rordorf, W. J. Koroshetz, M. A. Ezzeddine, A. Z. Segal, and F. S. Buonanno, “A pilot study of drug-induced hypertension for treatment of acute stroke,” Neurology, vol. 56, no. 9, pp. 1210–1213, 2001. View at Scopus
  26. R. M. Chestnut, N. Temkin, N. Carney, et al., “A trial of intracranial-pressure monitoring in traumatic brain injury,” The New England Journal of Medicine, vol. 367, no. 26, pp. 2471–2481, 2012. View at Publisher · View at Google Scholar
  27. J. I. Frank, “Large hemispheric infarction, deterioration, and intracranial pressure,” Neurology, vol. 45, no. 7, pp. 1286–1290, 1995. View at Scopus
  28. S. Schwab, A. Aschoff, M. Spranger, F. Albert, and W. Hacke, “The value of intracranial pressure monitoring in acute hemispheric stroke,” Neurology, vol. 47, no. 2, pp. 393–398, 1996. View at Scopus
  29. E. Keller, T. Steiner, J. Fandino, S. Schwab, and W. Hacke, “Jugular venous oxygen saturation thresholds in trauma patients may not extrapolate to ischemic stroke patients: lessons from a preliminary study,” Journal of Neurosurgical Anesthesiology, vol. 14, no. 2, pp. 130–136, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. P. J. Lindsberg and R. O. Roine, “Advances in stroke 2003: hyperglycemia in acute stroke,” Stroke, vol. 35, no. 2, pp. 363–364, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. S. E. Capes, D. Hunt, K. Malmberg, P. Pathak, and H. C. Gerstein, “Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview,” Stroke, vol. 32, no. 10, pp. 2426–2432, 2001. View at Scopus
  32. NICE-SUGAR Study Investigators, “Intensive versus conventional glucose control in critically ill patients,” The New England Journal of Medicine, vol. 360, no. 13, pp. 1283–1297, 2009.
  33. H. A. Choi, S. B. Ko, M. Presciutti et al., “Prevention of shivering during therapeutic temperature modulation: the Columbia anti-shivering protocol,” Neurocritical Care, vol. 14, no. 3, pp. 389–394, 2011. View at Publisher · View at Google Scholar · View at Scopus